![Han-Soo Keyoung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Han-Soo Keyoung
Directeur/Membre du Conseil chez
HUGEL, INC.
Fortune : 1 704 $ au 31/07/2026
Profil
Han-Soo Keyoung is Senior Managing Director & Head - Private Credit at C-Bridge Capital LLC since 2017.
Also holds positions as Independent Director at Kairos Pharma Ltd. starting 2024, Managing Director & Head-North America at C-Bridge Capital Partners LLC, Senior Managing Director at CBC Group (Singapore) Pte.
Ltd. since 2017, Non-Executive Director at Hugel, Inc. since 2022, and Founding Managing Partner at Portola Capital Partners since 2013.
Former roles include Chief Executive Officer at Fosun Pharma USA, Inc., President & Chief Executive Officer at Genexine, Inc. from 2015 to 2017, Chairman at AffaMed Therapeutics Co., Ltd., Director at InxMed Biotechnology Nanjing Co., Ltd., Director at SK Holdings, Inc., Director at Graybug Vision, Inc. from 2019 to 2021, Managing Director & Head - Pan-Asia at Burrill LLC from 2007 to 2013, Director at Korea Evaluation Institute of Industrial Technology, Chief Executive Director at Tasly Pharmaceuticals, Inc., Director at I-Mab Bio-tech (Tianjin) Co. Ltd. from 2015 to 2017, Founding Board Member at Everest Medicines Ltd. from 2017 to 2019, Founding Board Member at I-MAB Biopharma Co., Ltd. from 2015 to 2018, Founding Board Member at PT Kalbe Genexine Biologics from 2016 to 2017, and President at Catalyst Biosciences, Inc. from 2013 to 2015.
Education includes a doctorate from Weill Cornell Medical College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
KAIROS PHARMA, LTD. 0,03% | 31/03/2026 | 5 569 ( 0,03% ) | 1 704 $ | 31/07/2026 |
Postes actifs de Han-Soo Keyoung
| Sociétés | Poste | Début |
|---|---|---|
| KAIROS PHARMA, LTD. | Directeur/Membre du Conseil | 11/09/2024 |
| HUGEL, INC. | Directeur/Membre du Conseil | 29/04/2022 |
Portola Capital Partners
 Portola Capital Partners Investment ManagersFinance Portola Capital Partners invests in companies located in the United States. It participates in early stage capital requirements. | Private Equity Investor | 01/01/2013 |
C-Bridge Capital LLC
 C-Bridge Capital LLC Investment ManagersFinance C-Bridge Capital invest in companies located in the United States. The firm focuses on healthcare sub-sectors of pharma, biotech, medical devices, IVD and services. It participates in early stage transactions. | Private Equity Investor | 01/01/2017 |
CBC Group (Singapore) Pte. Ltd.
 CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group invests in middle market companies located in China. The firm focuses on pharmaceutical, biotechnology, medical technology and healthcare service sectors. It provides financing in the form of equity, debt and non-dilutive financing for for buyout, growth, royalty acquisitions, structured transactions and hybrid financings. It acquires controlling stake in the company. | Private Equity Investor | 01/01/2017 |
C-Bridge Capital Partners LLC | Corporate Officer/Principal | - |
Anciens postes connus de Han-Soo Keyoung
| Sociétés | Poste | Fin |
|---|---|---|
| CALCIMEDICA, INC. | Directeur/Membre du Conseil | 01/02/2021 |
| EVEREST MEDICINES LIMITED | Directeur/Membre du Conseil | 31/12/2019 |
I-MAB Biopharma Co., Ltd.
 I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology Operates as biotechnology company focuses on cancer immunity and autoimmune disease treatment | Directeur/Membre du Conseil | 31/12/2018 |
| ░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Han-Soo Keyoung
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
SK Holdings, Inc.
 SK Holdings, Inc. BroadcastingConsumer Services Part of Match Group, Inc., SK Holdings, Inc. is a company based in New York, NY. | Consumer Services |
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, which focuses on developing transformative medicines for the treatment of chronic diseases of retina and optic nerve | Health Technology |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burrill invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in buyout and early-stage transactions. | Finance |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genexine, Inc.
 Genexine, Inc. BiotechnologyHealth Technology Engages in the research and development of bio-pharmaceuticals | Health Technology |
Hugel, Inc.
 Hugel, Inc. BiotechnologyHealth Technology Manufactures and supplies toxin products, cosmetics, medical devices and pharmaceuticals | Health Technology |
Korea Evaluation Institute of Industrial Technology
 Korea Evaluation Institute of Industrial Technology Miscellaneous Commercial ServicesCommercial Services Operates as research institutes to develop technology for domestic industries | Commercial Services |
Portola Capital Partners
Portola Capital Partners Investment ManagersFinance Portola Capital Partners invests in companies located in the United States. It participates in early stage capital requirements. | Finance |
Tasly Pharmaceuticals, Inc.
 Tasly Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in research & development, production, wholesale & distribution of pharmaceutical products | Health Technology |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
I-Mab Bio-tech (Tianjin) Co. Ltd.
 I-Mab Bio-tech (Tianjin) Co. Ltd. BiotechnologyHealth Technology Develops biological and medicine products | Health Technology |
C-Bridge Capital Partners LLC | |
CBC Group (Singapore) Pte. Ltd.
CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group invests in middle market companies located in China. The firm focuses on pharmaceutical, biotechnology, medical technology and healthcare service sectors. It provides financing in the form of equity, debt and non-dilutive financing for for buyout, growth, royalty acquisitions, structured transactions and hybrid financings. It acquires controlling stake in the company. | Finance |
Everest Medicines Ltd.
 Everest Medicines Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies to address critical unmet medical needs | Health Technology |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology Operates as biotechnology company focuses on cancer immunity and autoimmune disease treatment | Health Technology |
PT Kalbe Genexine Biologics
 PT Kalbe Genexine Biologics BiotechnologyHealth Technology Manufactures biologic and immuno-oncology products | Health Technology |
AffaMed Therapeutics
 AffaMed Therapeutics Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutics for ophthalmology patients | Health Technology |
Fosun Pharma USA, Inc.
 Fosun Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical injectable products | Health Technology |
InxMed Biotechnology Nanjing Co., Ltd.
 InxMed Biotechnology Nanjing Co., Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
C-Bridge Capital LLC
C-Bridge Capital LLC Investment ManagersFinance C-Bridge Capital invest in companies located in the United States. The firm focuses on healthcare sub-sectors of pharma, biotech, medical devices, IVD and services. It participates in early stage transactions. | Finance |
Kairos Pharma Ltd.
 Kairos Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
